Literature DB >> 20456158

Post-traumatic headache: is it for real? Crossfire debates on headache: pro.

Mark Obermann1, Matthias Keidel, Hans-Christoph Diener.   

Abstract

Mild traumatic brain injury is very common in Western societies, affecting approximately 1.8 million individuals in the USA. Even though between 30% and 90% of patients develop post-traumatic headache, post-traumatic headache remains a very controversial disorder. Particularly when it comes to chronic post-traumatic headache following mild closed head injury and headache attributed to whiplash injury. Some experts are disputing its existence as a genuine disorder. Indistinct disease classification, unresolved pathophysiological mechanism, and the role of accident-related legal issues further fuel this controversy. The complex combination of pain and neuropsychological symptoms needs further research in understanding the underlying pathophysiological mechanisms associated with the acute headache following trauma but more so the mechanisms associated with the development of chronic pain in some patients. Investigators should refrain from oversimplifying these complex mechanisms as hysteric exaggeration of everyday complains and from implying greed as motivation for this potentially very disabling disease.

Entities:  

Mesh:

Year:  2010        PMID: 20456158     DOI: 10.1111/j.1526-4610.2010.01644.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

Review 1.  Neuroimaging biomarkers in mild traumatic brain injury (mTBI).

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2013-08-24       Impact factor: 7.444

Review 2.  Insights and advances in post-traumatic headache: research considerations.

Authors:  Teshamae S Monteith; David Borsook
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 3.  Headache after trauma: physiological considerations.

Authors:  Miguel J A Láinez; Begoña López Pesquera
Journal:  Curr Pain Headache Rep       Date:  2011-12

4.  Decreased grey matter volume in mTBI patients with post-traumatic headache compared to headache-free mTBI patients and healthy controls: a longitudinal MRI study.

Authors:  Shana A B Burrowes; Chandler Sours Rhodes; Timothy J Meeker; Joel D Greenspan; Rao P Gullapalli; David A Seminowicz
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

Review 5.  The Litigation Complexity of Posttraumatic Headaches.

Authors:  Jack E Hubbard; Samuel D Hodge
Journal:  Curr Pain Headache Rep       Date:  2021-04-06

6.  Change in Headache Suffering and Predictors of Headache after Mild Traumatic Brain Injury: A Population-Based, Controlled, Longitudinal Study with Twelve-Month Follow-Up.

Authors:  Lena H Nordhaug; Mattias Linde; Turid Follestad; Øystein Njølstad Skandsen; Vera Vik Bjarkø; Toril Skandsen; Anne Vik
Journal:  J Neurotrauma       Date:  2019-08-02       Impact factor: 5.269

7.  Characterization of persistent post-traumatic headache and management strategies in adolescents and young adults following mild traumatic brain injury.

Authors:  Simple Futarmal Kothari; Peter Preben Eggertsen; Oana Veronica Frederiksen; Mille Moeller Thastum; Susanne Wulff Svendsen; Astrid Tuborgh; Erhard Trillingsgaard Næss-Schmidt; Charlotte Ulrikka Rask; Andreas Schröder; Helge Kasch; Jørgen Feldbæk Nielsen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

8.  Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury.

Authors:  Andrew B Newberg; Mijail Serruya; Andrew Gepty; Charles Intenzo; Todd Lewis; Daniel Amen; David S Russell; Nancy Wintering
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

9.  A double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trial.

Authors:  Karen M Barlow; Brian L Brooks; Frank P MacMaster; Adam Kirton; Trevor Seeger; Michael Esser; Susan Crawford; Alberto Nettel-Aguirre; Roger Zemek; Mikrogianakis Angelo; Valerie Kirk; Carolyn A Emery; David Johnson; Michael D Hill; Jeff Buchhalter; Brenda Turley; Lawrence Richer; Robert Platt; Jamie Hutchison; Deborah Dewey
Journal:  Trials       Date:  2014-07-07       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.